How should NIH improve peer review?

Today, the NIH linkurl:announced;http://www.nih.gov/news/pr/jun2007/od-08.htm that it was establishing two working groups to examine its peer review process. That process has been under increased scrutiny recently, as study sections have needed to read more and more grant applications with every cycle. And with NIH funding flat, it's no longer good enough to be in the top 30% or so to get funded; in some study sections, it's close to 10%. So many scientists may find the examination welcome. In

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Today, the NIH linkurl:announced;http://www.nih.gov/news/pr/jun2007/od-08.htm that it was establishing two working groups to examine its peer review process. That process has been under increased scrutiny recently, as study sections have needed to read more and more grant applications with every cycle. And with NIH funding flat, it's no longer good enough to be in the top 30% or so to get funded; in some study sections, it's close to 10%. So many scientists may find the examination welcome. In 2005, in the pages of The Scientist, David Kaplan linkurl:proposed;http://www.the-scientist.com/article/display/15701/ a number of ways to improve peer review at the NIH. What do you think of his suggestions, which include decreasing the length of the research plan to between two and four pages so that 20 to 30 reviews for each application could be solicited, and doing away with committee meetings? Where do you suggest the new committees look for improvements? Give us your ideas by linkurl:commenting;http://www.the-scientist.com/forum/addcomment/53276/ on this blog.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ivan Oransky

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio